Clinical Trial Update: Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the role of a non-selective beta-adrenergic blocker in severe traumatic brain injury, focusing on intracranial pressu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Non-Selective Beta-Adrenergic Blocker

Snippet

Sponsor: Tanta University | Conditions: Traumatic Brain Injury (TBI) Patients, Intracranial Pressure | Phase 3 | Status: NOT_YET_RECRUITING